JPS60197703A - Polymer excellent in endotoxin adsorptivity and its molding - Google Patents
Polymer excellent in endotoxin adsorptivity and its moldingInfo
- Publication number
- JPS60197703A JPS60197703A JP59051166A JP5116684A JPS60197703A JP S60197703 A JPS60197703 A JP S60197703A JP 59051166 A JP59051166 A JP 59051166A JP 5116684 A JP5116684 A JP 5116684A JP S60197703 A JPS60197703 A JP S60197703A
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- alpha
- fiber
- aromatic vinyl
- vinyl polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- External Artificial Organs (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
【発明の詳細な説明】 (発明の技術分野) 本発明は内毒素の吸着剤に関する。[Detailed description of the invention] (Technical field of invention) The present invention relates to endotoxin adsorbents.
内**は哺乳動物の血中に入ると発熱性と毒性を示す物
質である。これは、大腸菌、サルモネラ菌、緑膿菌で代
表されるグラム隘性菌の細胞壁外膜から由来するリボ多
糖体またはリボ多糖体・タンパク質複合体であって、高
圧蒸気滅菌でも分解 ・できない程、熱に安定な物質で
ある。** is a substance that exhibits pyrogenicity and toxicity when it enters the blood of mammals. This is a ribopolysaccharide or ribopolysaccharide-protein complex derived from the outer membrane of the cell wall of Gram bacteria such as Escherichia coli, Salmonella enterica, and Pseudomonas aeruginosa. It is a stable substance.
したがって、消化管を経ないで生体内に直接投与する注
射用の水・生理的食塩水、ブドウ糖やビタミンなどの栄
養成分を含む輸液、白液透析用の。Therefore, water for injection and physiological saline that is administered directly into the living body without passing through the gastrointestinal tract, infusions containing nutritional components such as glucose and vitamins, and white fluid for dialysis.
透析液、アルブミン等のタンパク質を含む輸液などには
、内毒素が混入してはならない。Dialysate fluids and infusions containing proteins such as albumin must not be contaminated with endotoxins.
内毒素の吸着剤としてイオン交換樹脂が知られているが
、その吸着容量は小さく、実用化されていない。Ion exchange resins are known as adsorbents for endotoxins, but their adsorption capacity is small and they have not been put to practical use.
(発明の目的)
内毒素に対する吸着容量の大きな吸着剤を見い出すこと
。(Objective of the invention) To find an adsorbent with a large adsorption capacity for endotoxins.
(発明の構成)
本発明は側鎖として、下記一般式(1)で示される官能
基を導入した芳香核を有するビニル系重合体およびそに
成型品。(Structure of the Invention) The present invention relates to a vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (1) is introduced as a side chain, and a molded product thereof.
上式中、R1は炭素数にして4個以上、10個以下のメ
チレン鎖長を有するアルキル基を示し、R2およびR3
はメチル基またはエチル基を示す。In the above formula, R1 represents an alkyl group having a methylene chain length of 4 to 10 carbon atoms, and R2 and R3
represents a methyl group or an ethyl group.
またR4およびR5は水素原子または低級アルキル基を
示す。Xは塩素イオンで代表される通常の陰イオンを示
す。Further, R4 and R5 represent a hydrogen atom or a lower alkyl group. X represents a normal anion represented by a chlorine ion.
を提供するものである。It provides:
本発明の重合体およびその成型品は、イオン交換樹脂の
10倍以上の内毒素の除去のほか、内毒l#崩症治療に
用いることができる。The polymer of the present invention and its molded product can be used not only to remove endotoxins ten times more than ion exchange resins, but also to treat endotoxin I# collapse disease.
本発明でいう芳香核を有するビニル系重合体とはスチレ
ン、α−メチルスチレン、ビニルトルエンなどで代表さ
れる芳香核を有するビニル系モノマノT11独重合体も
゛しくはこれらを主成分とする共重合体を意味し、これ
らの重合体は架橋されていればさらに好ましい。また該
重合体は結晶性ポリプロピしン、ポリエチレンなどで代
表されるポリα−オレフィンで補強されていれば、機械
的性質が向上するので、さらに好ましい。例えば、ジビ
ニルベンゼンあるいはメチレンビスアクリルアミド等で
代表されるポリビニル化合物との共重合体のほか、上記
モノビニル化合物重合体成形品をホルムアルデヒド、ク
ロルスルホン酸等で架橋処理したもの等があげられる。In the present invention, the vinyl polymer having an aromatic nucleus is a vinyl monomer T11 monopolymer having an aromatic nucleus represented by styrene, α-methylstyrene, vinyltoluene, etc., or a copolymer having these as the main component. It refers to polymers, and it is more preferred if these polymers are crosslinked. Further, it is more preferable that the polymer is reinforced with a polyα-olefin such as crystalline polypropylene or polyethylene, since the mechanical properties will be improved. Examples include copolymers with polyvinyl compounds such as divinylbenzene or methylenebisacrylamide, as well as monovinyl compound polymer molded products crosslinked with formaldehyde, chlorosulfonic acid, etc.
架橋重合体は流動性がなく、成形が困難なので、該重合
体成形品がmei、膜等の場合は成形後架橋処理する方
法が好ましく採用される。Crosslinked polymers have no fluidity and are difficult to mold, so when the polymer molded product is a mei, a membrane, etc., a method of crosslinking after molding is preferably employed.
上記一般式(1)中、アルキルJIR1のメチレン鎖長
は短すぎても長ずぎても吸着能力が小さくなる。In the above general formula (1), if the methylene chain length of alkyl JIR1 is too short or too long, the adsorption capacity will be reduced.
R2およびRsのアルキル基はメチル基が最良である。The alkyl group for R2 and Rs is preferably a methyl group.
R4およびR5のアルキル基は水素原子である場合が最
も製造しやすい。It is easiest to manufacture when the alkyl groups of R4 and R5 are hydrogen atoms.
本発明成形品の表面積はあまり小さすぎると、固定化密
度が低くなるが、あまり大きすぎても、本発明成形品を
充填したカーラムの通液性が悪くなるので該成形品の表
面積は0.01以上50が/9以下、より好ましくは、
0.05以上10m’/9以下がよい。If the surface area of the molded article of the present invention is too small, the immobilization density will be low, but if it is too large, the liquid permeability of the column filled with the molded article of the present invention will be poor, so the surface area of the molded article will be 0. 01 or more and 50 is /9 or less, more preferably,
It is preferably 0.05 or more and 10 m'/9 or less.
本発明重合体中の上記一般式(1)で示される官能基の
量には特に限定はないが、少なすぎると本発明重合体お
よびその成形品と溶液との親和性が悪くなり、内毒素吸
着能が低下するので、該重合体“1gあたり、0.5ミ
リモル以上、より好ましくは1.0ミリモル以上存在す
るのがよい。There is no particular limitation on the amount of the functional group represented by the above general formula (1) in the polymer of the present invention, but if it is too small, the affinity of the polymer of the present invention and its molded products with the solution will deteriorate, leading to endotoxic Since the adsorption capacity decreases, it is preferable that the amount is 0.5 mmol or more, more preferably 1.0 mmol or more per 1 g of the polymer.
以下に実施例を示す。Examples are shown below.
実施例1
ポリプロピレン(三井“ノーブレン”J3HG)50分
を島成分とし、ポリスチレン(スタイロン”666)4
6分、ポリプロピレン(住友“ノーブレン”WF−72
7−F)4分の混合物を海成分とする海島型複合m1l
I(島数16、単糸繊度2゜6デニール、引張強度2.
9cy/d、伸度50%、フィラメント数42>100
0を、N−メチロール−α−クロルアセトアミド120
Q、ニトロベンゼン8000.およびバラホルムアルデ
ヒド1.7gからなる混合溶液中に浸し、20℃で1時
間反応させた。繊維を反応液から取、り出し、0℃の氷
水10n中に投じて、反応停止させたのち、水で洗浄し
、次に、繊維に付着しているニトロベンゼンをメタノー
ルで抽出除去した。この繊維(繊111A)を50℃で
真空乾燥して、クロルアセトアミドメチル化繊1ft7
1 a (IImA)を得た。Example 1 Polypropylene (Mitsui "Noblen" J3HG) 50 minutes was used as the island component, polystyrene (Styron" 666) 4
6 minutes, polypropylene (Sumitomo “Noblen” WF-72
7-F) Sea-island type composite m1l with 4-minute mixture as sea component
I (number of islands 16, single yarn fineness 2°6 denier, tensile strength 2.
9cy/d, elongation 50%, number of filaments 42>100
0, N-methylol-α-chloroacetamide 120
Q. Nitrobenzene 8000. The sample was immersed in a mixed solution consisting of 1.7 g of rose formaldehyde and reacted at 20° C. for 1 hour. The fibers were taken out from the reaction solution and poured into 10 nm of ice water at 0° C. to stop the reaction, and then washed with water, and then the nitrobenzene adhering to the fibers was extracted and removed with methanol. This fiber (fiber 111A) was vacuum dried at 50°C to produce 1ft7 chloracetamide methyl synthetic fiber.
1a (IImA) was obtained.
上記で得た繊維A10(lを1009のヨウ化カリウム
を含む10%含水エタノール2Qに浸し、50℃で゛4
時間加熱して、□ヨードアセトアミドメチル化繊維(繊
1ftB>を冑だ。The fiber A10 (l) obtained above was immersed in 10% aqueous ethanol 2Q containing 1009 potassium iodide, and heated to 50℃ for 4 hours.
Heat for a period of time and dry the □ iodoacetamide methylated fiber (1 ftB of fiber).
繊$181(lをN、N−ジメヂルヘキシルアミン30
Qおよびジメチルホルムアミド1709からなる溶液に
浸し、80℃で5時間加熱した。さらに、この繊維をク
ロマトカラムにつめ、1nの1N−塩酸、5Qの水、1
aの1N−カセイソーダ水、5aの水および10gの1
M−食塩水で、順次、洗浄して、塩化N、N−ジメチル
−N−ヘキシルアンモニウムアセトアミドメチル化繊雑
(本発明試料1)を得た。このものは、中性塩分解容量
が
1.83ミリ当M!/Q、弱塩基性基量が0.05ミリ
当量10で、CI型含水度は1.9であった。Fiber $181 (l = N, N-dimedylhexylamine 30
It was immersed in a solution consisting of Q and dimethylformamide 1709 and heated at 80°C for 5 hours. Furthermore, this fiber was packed in a chromatography column, 1N of 1N-hydrochloric acid, 5Q of water, 1
a 1N caustic soda water, 5a water and 10g 1
The mixture was sequentially washed with M-saline solution to obtain N,N-dimethyl-N-hexylammonium acetamidomethyl chloride (sample 1 of the present invention). This product has a neutral salt decomposition capacity of 1.83 milliliters! /Q, the amount of weak basic group was 0.05 milliequivalent 10, and the CI type water content was 1.9.
実施例2
実施例1で得た繊維B10QをN、N−ジメチルオクチ
ルアミン300およびジメチルホルムアミド2700の
混合溶液に浸し、80℃で5時間加熱した。さらに、こ
の繊維を、ソックスレー抽出器で、10時間メタノール
抽出したのち、クロマトカラムにつめ、1aの1N−塩
酸、5αの水、1Qの1N−カセイソーダ水、5Qの水
および10Qの1M−良塩水で洗浄して、塩化N 、、
N−ジメタルーN−オクチルアンモニウムアセトアミ
トメデル化繊緒(本発明試料2)を得た。このものは、
中性塩分解容量が1.72ミリ当fIi/g、弱塩基性
基量が0.05ミリ当量/Qで、C+型含水度は1.3
であった。Example 2 The fiber B10Q obtained in Example 1 was immersed in a mixed solution of 300% N,N-dimethyloctylamine and 2700% dimethylformamide, and heated at 80°C for 5 hours. Furthermore, this fiber was extracted with methanol for 10 hours using a Soxhlet extractor, and then packed into a chromatography column. Wash with N chloride,
N-dimetal-N-octylammonium acetamidol synthetic fiber (sample 2 of the present invention) was obtained. This thing is
The neutral salt decomposition capacity is 1.72 milliequivalent fIi/g, the amount of weak basic group is 0.05 milliequivalent/Q, and the C+ type water content is 1.3.
Met.
実施例3
本発明試料1、本発明試料2および比較試料1について
、以下の内毒素吸着実験を行なった。Example 3 The following endotoxin adsorption experiment was conducted on Inventive Sample 1, Inventive Sample 2, and Comparative Sample 1.
各試料毎に6本の試験管(外形24mm)を用意し、そ
の中に15−g、30−g、5010.80+oq16
01!IIおよび3・00■9の試料を入れ、つぎに、
10−Iのリボ多糖体水溶液(E、 Co11 055
:B5、トリクロル酢酸抽出法、ディフコラボラトリ
ーズ社製、0 、11 gio/ml)を入れて、37
℃で6時間振とうしたのち、No、2の定性濾紙で濾過
し、濾液についてリポ多糖体の濃度をフェノール・硫酸
法(試料21+5%フェノール水1−1+98%硫酸5
sl:485−μ)で測定した。母液中のリボ多糖体濃
度と初期濃度(0,11ma/ll)との差を吸着され
たリボ多糖体量とみなし、等温吸着線をめた。各試料の
吸te能を比較するため、母液濃度が0.05ma/m
lのときの吸着能を等渦@着線からめた結果を表1に示
す。Prepare 6 test tubes (outer diameter 24 mm) for each sample, and in them 15-g, 30-g, 5010.80 + 16 oz.
01! Insert the samples II and 3.00■9, and then
10-I ribopolysaccharide aqueous solution (E, Co11 055
: B5, trichloroacetic acid extraction method, manufactured by Difco Laboratories, 0, 11 gio/ml), 37
After shaking at ℃ for 6 hours, it was filtered through a No. 2 qualitative filter paper, and the concentration of lipopolysaccharide in the filtrate was determined using the phenol-sulfuric acid method (sample 21 + 5% phenol water 1-1 + 98% sulfuric acid 5).
sl:485-μ). The difference between the ribopolysaccharide concentration in the mother liquor and the initial concentration (0.11 ma/ll) was regarded as the amount of adsorbed ribopolysaccharide, and an isothermal adsorption line was drawn. In order to compare the absorption capacity of each sample, the mother liquor concentration was 0.05 ma/m
Table 1 shows the results of considering the adsorption capacity when 1 is equal to the constant vortex @ wire attachment.
表 1
但し、比較試料1は、実施例2のN、N−ジメチルオク
チルアミンの代りに、N、N−ジメチルラウリルアミン
を用いる他は実施例1と全く同様に処理して調製した塩
化N、N−ジメチルーN−ラウリルアンモニウムアセト
アミドメチル化繊雑で、その中性塩分解容量は0.73
ミリ当量/Qで、弱塩基はなく、C1型含水度はO,’
71であった。比較試料2は、実施例1で得た繊11B
をトリn−ブチルアミンの15%DMSO・エタノール
(1:1)溶液中55℃で8時間加熱して得た塩化トリ
n−ブチルアンモニウムアセトアミドメチル化繊維で、
ぞの中性塩分解容量は1.50ミリ当量/gで、弱塩基
性IMは0.02ミリ当陪/Q、CI型含水度は1.5
7であった。比較試料3は、実施例1の繊INIBをト
リn−プロピルアミンの20%DMSO・エタノール(
1:1)溶液中55℃で8時間加熱して得た塩化トリn
−プロピルアンモニウムアセトアミドメチル化Illで
あり、その中性塩分解容量は1.64ミリ当量10で、
弱塩基性基はなく、CI型含水度は、1゜57であった
。比較試料4は、実施例1の繊11Bをトリエチルアン
モニウムの25%エタノール溶液中55℃で5時間加熱
して得た塩化トリエチルアンモニウムアセトアミドメチ
ル化りl雑であり、その中性塩分解容量は1.56ミリ
当@/gで、弱塩基性基量は0.09ミリ当量/gで、
CI型含水度は1.20であった。Table 1 However, Comparative Sample 1 is N chloride, prepared in exactly the same manner as in Example 1, except that N,N-dimethyllaurylamine is used instead of N,N-dimethyloctylamine in Example 2. N-dimethyl-N-lauryl ammonium acetamidomethyl compound, its neutral salt decomposition capacity is 0.73
Milliequivalent/Q, no weak base, C1 type water content O,'
It was 71. Comparative sample 2 is fiber 11B obtained in Example 1.
tri-n-butylammonium chloride acetamidomethylated fiber obtained by heating at 55°C for 8 hours in a 15% DMSO/ethanol (1:1) solution of tri-n-butylamine,
Its neutral salt decomposition capacity is 1.50 meq/g, weakly basic IM is 0.02 meq/Q, and type CI water content is 1.5.
It was 7. Comparative sample 3 was prepared by mixing the fiber INIB of Example 1 with tri-n-propylamine in 20% DMSO/ethanol (
1:1) trichloride obtained by heating at 55°C for 8 hours in solution
- propylammonium acetamidomethylated Ill, whose neutral salt decomposition capacity is 1.64 meq. 10;
There were no weakly basic groups, and the CI type water content was 1°57. Comparative sample 4 is a triethylammonium chloride acetamidomethylated mixture obtained by heating the fiber 11B of Example 1 at 55° C. for 5 hours in a 25% ethanol solution of triethylammonium, and its neutral salt decomposition capacity is 1. .56 meq@/g, the amount of weak basic group is 0.09 meq/g,
Type CI moisture content was 1.20.
表1から本発明試料はイオン交換樹脂の10倍以上の内
毒素吸着能があることがわかる。また、比較試料1〜4
は官能基の秒類や炭素数の点で本発明試料とほとんど変
わらないにもかかわらず゛、内毒素に対する@普能はは
るかに小さい。このことから、本発明重合体の一般式(
1)で示される官能基の構造が、内毒素に対して特別な
親和性を持っていることがわかる。Table 1 shows that the sample of the present invention has an endotoxin adsorption capacity that is 10 times or more that of the ion exchange resin. In addition, comparative samples 1 to 4
Although it is almost the same as the sample of the present invention in terms of the number of functional groups and the number of carbon atoms, its sensitivity to endotoxin is much smaller. From this, the general formula (
It can be seen that the structure of the functional group shown in 1) has a special affinity for endotoxins.
特許出願人 東 し 株 式 会 社Patent applicant Higashi Shikikai Co., Ltd.
Claims (1)
した芳香核を有するビニル系重合体およびその成型品。 上式中、R1は炭素数にして4個以上、10個以下のメ
チレン鎖長を有するアルキル基を示し、R2およびR3
はメチル基またはエチル基を示す。 またR4およびR5は水素原子または低級アルキル基を
示す。Xは塩素イオンで代表される通常の陰イオンを示
す。[Scope of Claims] A vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (1) is introduced as a side chain, and a molded product thereof. In the above formula, R1 represents an alkyl group having a methylene chain length of 4 to 10 carbon atoms, and R2 and R3
represents a methyl group or an ethyl group. Further, R4 and R5 represent a hydrogen atom or a lower alkyl group. X represents a normal anion represented by a chlorine ion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59051166A JPS60197703A (en) | 1984-03-19 | 1984-03-19 | Polymer excellent in endotoxin adsorptivity and its molding |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59051166A JPS60197703A (en) | 1984-03-19 | 1984-03-19 | Polymer excellent in endotoxin adsorptivity and its molding |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60197703A true JPS60197703A (en) | 1985-10-07 |
JPH0356741B2 JPH0356741B2 (en) | 1991-08-29 |
Family
ID=12879235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59051166A Granted JPS60197703A (en) | 1984-03-19 | 1984-03-19 | Polymer excellent in endotoxin adsorptivity and its molding |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60197703A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003101511A1 (en) | 2002-05-30 | 2003-12-11 | Toray Industries, Inc. | Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5712008A (en) * | 1980-06-27 | 1982-01-21 | Toray Ind Inc | Aromatic vinyl polymer having novel functional group and production thereof |
-
1984
- 1984-03-19 JP JP59051166A patent/JPS60197703A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5712008A (en) * | 1980-06-27 | 1982-01-21 | Toray Ind Inc | Aromatic vinyl polymer having novel functional group and production thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003101511A1 (en) | 2002-05-30 | 2003-12-11 | Toray Industries, Inc. | Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer |
EP1532993A4 (en) * | 2002-05-30 | 2010-09-29 | Toray Industries | Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer |
Also Published As
Publication number | Publication date |
---|---|
JPH0356741B2 (en) | 1991-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6303702B1 (en) | Method of producing material for purification of physiological liquids of organism | |
DE68910175T3 (en) | Adsorber module and adsorber apparatus for the treatment of whole blood. | |
US5401499A (en) | Method of adsorbing pyrogens | |
JP4983070B2 (en) | Adsorbent and extracorporeal circulation column | |
WO1996025228A1 (en) | ADSORBENT FOR TUMOR NECROSIS FACTOR α, METHOD OF REMOVAL BY ADSORPTION, AND ADSORPTION DEVICE USING SAID ADSORBENT | |
US6527735B1 (en) | Method of peritoneal dialysis | |
JP2019136499A (en) | Material for removing activated leukocyte-activated platelet complex | |
JPS60197703A (en) | Polymer excellent in endotoxin adsorptivity and its molding | |
US9982369B2 (en) | Fiber and column for protein adsorption | |
JP4032465B2 (en) | Thrombogenic substance adsorbent and extracorporeal circulation column | |
JPS60246766A (en) | Blood treating agent | |
JPS6087854A (en) | Adsorbent for purifying blood | |
JPS6219178A (en) | Material and method for removing endotoxin | |
JP4182682B2 (en) | Carcinoembryonic antigen adsorbent and extracorporeal circulation column | |
JPS5923852B2 (en) | Adsorption methods for ionic and polar substances | |
JPS6194663A (en) | Blood treating agent | |
JPH039421B2 (en) | ||
JPH0585192B2 (en) | ||
JP2575487B2 (en) | Blood treatment material and blood purifier | |
JPH031324B2 (en) | ||
JP2002035118A (en) | Column for treating inflammatory disease | |
JP2000288388A (en) | Adsorbent for tumor necrosis factor-alpha, method for adsorption/removal, and adsorption device | |
JPS60209525A (en) | Alexeteric adsorbent for endotoxin | |
JPH0312900B2 (en) | ||
JPS6319154A (en) | Beta 2-microglobulin adsorbent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |